QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs
QIAGEN has launched the EZ2 Connect MDx platform for diagnostic laboratories, enhancing sample processing capabilities 18 months after its research introduction. This automated device purifies DNA and RNA from 24 samples in approximately 30 minutes and is CE-IVD compliant, enabling its use across the EU, U.S., Canada, and more. With over 5,000 EZ platforms deployed globally, EZ2 Connect MDx integrates with the QIAsphere digital system for remote management, meeting the fast-paced demands of clinical diagnostics. It addresses various sample types, employing magnetic-bead technology and ensuring high process safety.
- Launch of EZ2 Connect MDx enhances market reach in diagnostics.
- CE-IVD compliance allows access to EU and other international markets.
- The platform can process 24 samples in about 30 minutes, increasing lab efficiency.
- Over 5,000 cumulative placements of EZ platforms worldwide highlight strong market acceptance.
- Integration with QIAsphere digital system improves lab management and operation.
- None.
- Start of worldwide diagnostic use follows the launch of upgraded EZ2 Connect for research use in 2021, builds on the success of EZ1 Connect platform found in thousands of labs worldwide
- EZ2 Connect MDx puts standardized, efficient nucleic acid purification in reach of any clinical lab combined with QIAsphere digital system that allows for remote instrument management
- Over 5,000 cumulative placements of EZ platforms worldwide through the end of 2022
VENLO,
With a high degree of automation, the EZ2 Connect MDx enables labs to purify DNA and RNA from 24 samples in parallel in as little as 30 minutes1. The device now carries the EU’s CE-IVD compliance marking for in-vitro devices (IVD) for the
“EZ2 Connect MDx puts standardized and efficient nucleic acid purification in reach of any clinical lab,” said
EZ2 Connect MDx can extract nucleic acids from blood plasma, serum, stool and other sample types using magnetic-bead technology. High process safety is ensured with prefilled and sealed reagent cartridges, as well as load checking through integrated cameras. Other features include UV decontamination, onboard pipetting and heating as well as automated piercing of the sealed cartridge. The resulting analyte is compatible with a variety of downstream technologies such as real-time PCR, digital PCR and next-generation sequencing.
EZ2 Connect MDx complements QIAGEN’s leading offering of automated IVD nucleic extraction platforms, which includes QIAcube Connect MDx and QIAsymphony.
EZ2 Connect MDx is designed to handle a wide range of sample material thanks to QIAGEN’s elaborate kit portfolio and customizable protocols. It can be used in research mode with research kits (MBA) or in dedicated IVD mode with EZ1 DSP kits as well as protocols for diagnostic workflows. Another key feature is the ability to use the QIAsphere digital laboratory ecosystem, which enables full integration into the digital infrastructure of a lab that allows for remote instrument management.
The new platform builds on QIAGEN’s EZ1 family of devices, which set new standards in sample-prep automation and sample-data management. The EZ2 combines the ease of use, process safety and robustness of the EZ1 with improved throughput and digital features. More than 5,000 EZ1 and EZ2 instruments have been placed worldwide through the end of 2022.
To learn more about EZ2 Connect MDx, please visit: https://www.qiagen.com/products/ez2-connect-mdx
About
Forward-Looking Statement
Certain statements contained in this press release may be considered forward-looking statements within the meaning of Section 27A of the
1 Protocol run time varies depending on the number of samples processed and the protocol selected.
Source:
Category: Corporate
View source version on businesswire.com: https://www.businesswire.com/news/home/20230117005568/en/
Investor Relations
+49 2103 29 11711
+49 2103 29 11457
e-mail: ir@QIAGEN.com
Public Relations
+49 2103 29 11826
Daniela Eltrop
e-mail: pr@QIAGEN.com
Source:
FAQ
What is the significance of the EZ2 Connect MDx launch for QGEN?
What does CE-IVD compliance mean for QIAGEN's EZ2 Connect MDx?
How many samples can EZ2 Connect MDx process at once?
What technology does EZ2 Connect MDx use for nucleic acid extraction?